Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
1 day-14.62%
1 week-14.29%
Current month-14.62%
1 month-11.13%
3 months-7.50%
6 months+3.84%
Current year+1.28%
1 week 1,110
Extreme 1110
1,300
1 month 999
Extreme 999
1,300
Current year 805
Extreme 805
1,600
1 year 805
Extreme 805
1,600
3 years 805
Extreme 805
2,695
5 years 805
Extreme 805
5,100
10 years 805
Extreme 805
7,430
Manager TitleAgeSince
Chief Executive Officer 64 -
Chief Tech/Sci/R&D Officer 61 2025-03-23
Corporate Officer/Principal 60 -
Director TitleAgeSince
Director/Board Member 64 -
Director/Board Member 60 -
Director/Board Member 61 2025-03-23
Change 5-day change 1-year change 3-year change Capi.($)
-14.62%-14.29%-20.43%-57.23% 4.1M
-2.41%+0.14%+38.28%+153.06% 1,010B
+1.07%+3.48%+53.32%+49.09% 580B
+1.32%+0.22%+19.18%+67.17% 402B
+0.77%0.00%+21.28%+19.14% 330B
+0.44%+3.48%+25.65%+36.16% 281B
-0.85%-2.86%+22.54%+16.96% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+59.80% 192B
-0.22%-2.76%+14.19%+61.12% 156B
Average -1.25%-0.70%+15.00%+35.79% 342.89B
Weighted average by Cap. -0.23%+1.04%+27.77%+70.87%
Logo Genotech Corporation
Genotech Corporation is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) & Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results.
Employees
-
Date Price Change Volume
26-06-12 1,110.00 -14.62% 97
26-06-11 1,300.00 +0.39% 5
  1. Stock Market
  2. Stocks
  3. A066830 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!